Providing fractional CFO advice for Cannadorf, a pharma-grade medical cannabis company.

We've advised Cannadorf, a leader in pharmaceutical-grade manufacturing technology for cannabinoids, bridging latest agriculture developments to the medicine industry.

Tel Aviv, Israel
·24 February 2022

Overview

Management of Cannadorf required an actionable valuation service in order to accurately position the business in the upcoming capital raising discussions.

We have provided an independent valuation opinion that included deep dive on medical cannabis space, development pipeline analysis, risk-adjusted NPV (rNPV), comparable environment analysis, operational benchmarking, green/red flag analysis and more.

This transaction continues Flow's successful track record of advising in the digital health sector, having also advised and valued companies like Cannabis Innovation Center (medical cannabis), Code Pharma, BiomX (biotechnology) or AVE & YOU (personalized skincare).

About Cannadorf

Founded in 2019 and led by Kobi Buxdorf, Cannadorf is a world leader in state-of-the-art tissue culture technologies, for advanced industrial growth of flowering plants, focused on cannabis for medical and pharmaceutical use cases. Cannadorf technology is based on many years of academic research and development with collaboration from top researchers at The Hebrew University of Jerusalem.

About Flow Partners

Flow Partners provides founder-friendly corporate finance and fractional CFO advice to technology entrepreneurs globally. Flow was founded in 2020 and operates globally with presence in London, Berlin, Warsaw and Miami.

For more information, please visit flowpartners.io.

Enquires

For all enquiries please contact the team at hi@flowpartners.io

More clients we've worked with

Fractional CFO

Stages

Countries

Cities

Sectors

© 2026 Flow Partners (London) Ltd. All rights reserved. Registered as a limited liability company in England and Wales (registered number 12969521).

Providing fractional CFO advice for Cannadorf, a pharma-grade medical cannabis company. | Flow Partners